arrow
J

Jürgen K. Rockstroh

bonn university hospital
H指数:83
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates

2022年意大利、罗马尼亚和西班牙乙型肝炎和丙型肝炎相关死亡人数估计值

2026-06-190
OAAI
Long-term immune recovery under continuous antiretroviral therapy (ART) among ART-naive people living with HIV in two cohorts in Germany

在德国两个队列中,ART初治的HIV感染者在接受持续抗逆转录病毒治疗(ART)后的长期免疫重建

2026-02-260
OAAI
HIV-1 virologic failure in the RESINA cohort: lessons from two decades of real-world data

RESINA队列中HIV-1病毒学失败:来自二十年真实世界数据的经验教训

2025-12-170
OAAI
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial

整合酶抑制剂与蛋白酶抑制剂疗法在晚期HIV疾病中的比较(LAPTOP):一项多国家、随机、开放标签、非劣效性试验

2025-12-010
OAAI
Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe

循环HBV RNA和乙型肝炎核心相关抗原作为欧洲HIV感染者中HBsAg消失的判定指标

2025-11-070
OAAI
Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany

德国人类免疫缺陷病毒与乙型肝炎病毒合并感染者中丁型肝炎病毒的感染流行率

2025-11-070
OAAI
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025

欧洲艾滋病临床学会指南2025年第13.0版重大修订版。

2025-10-150
OAAI
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysis

人类免疫缺陷病毒感染者中晚期诊断者使用DTG/3TC或BIC/TAF/FTC启动抗逆转录病毒治疗:一项真实世界队列分析

2025-10-070
PRE
Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial Human Immunodeficiency Virus Type 1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial
2025-03-010
PRE
Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south

在全球南部使用废弃的避孕套进行基于社区的mpox和性传播疾病监测

2024-10-010
PRE